This report analyses the global and South African Allergy Care markets, examining value and volume trends, channel dynamics, and rising demand for gentle and convenient solutions. It highlights innovation in nasal sprays, paediatric formulations, rinse kits, and aromatherapy-infused products.
With manufacturer and retail profiles and pricing benchmarks, the report equips stakeholders with insight into segmentation, consumer expectations, and strategies to drive growth in this essential OTC category.
With allergy-related symptoms and conditions on the rise amongst children, an increasing number of parents and caregivers are seeking solutions that are both effective and child-friendly. In response, a growing number of companies are shifting their focus toward developing and launching products specifically designed for children. These offerings are positioned as safe, convenient, and effective ways to manage allergy symptoms while enhancing children’s overall well-being.
Globally, brands like Stallergenes Greer and ARS Pharmaceuticals are introducing child-specific solutions, such as Palforzia for peanut allergies and Neffy, a needle-free epinephrine spray. Mucinex® has also expanded its nasal care line with a dual-nozzle spray tailored for young users.
In South Africa, innovations include Aller-G’s allergen introduction sachets and Dr. Reddy’s fast-dissolving Allerway Meltaway 5 tablets. Telfast® has updated its Suspension packaging to be more appealing and user-friendly, reflecting the growing focus on accessible, child-friendly Allergy Care formats.
Our team will respond within the next 24 hours, sooner if possible.
If the inquiry is more urgent, please call 021 045 0202 (Cape Town) or 010 140 5756 (Johannesburg).